Exact Sciences Corp (NAS:EXAS)
$ 49.84 -4.24 (-7.84%) Market Cap: 9.20 Bil Enterprise Value: 11.10 Bil PE Ratio: 0 PB Ratio: 2.93 GF Score: 80/100

Exact Sciences Corp at Citi Healthcare & Medtech Conference Transcript

Mar 01, 2023 / 07:45PM GMT
Release Date Price: $62.45 (+0.19%)
Patrick Bernard Donnelly
Citigroup Inc., Research Division - Senior Analyst

We'll get started. Thanks, everyone, for joining us. I'm Patrick Donnelly, Tools and Diagnostics analyst here at Citi. Happy to have Jeff Elliott, the CFO, COO of Exact Sciences with us. A lot to go through, obviously, with you guys.

Questions & Answers

Patrick Bernard Donnelly
Citigroup Inc., Research Division - Senior Analyst

Maybe we can start off just on -- just chatting about it, just on the 4Q kind of number and then that progression into 1Q. I know there were some revenue recognition in the 4Q piece in terms of some catch-up.

So maybe talk through the 4Q results, obviously really strong, kind of what inflected there. And then again, maybe -- say onetime, but maybe some benefits there that kind of won't quite recur.

Jeffrey T. Elliott
Exact Sciences Corporation - Executive VP, CFO & COO

Sure. Thanks, Patrick. Thanks, everyone in the room, and thanks Citi for having us. Great to be back here in person. So we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot